Mandatory notification of trade - exercise of employee share options NewsRonny SkuggedalApril 27, 2015
PCI Biotech initiates pre-clinical research collaboration in siRNA therapeutics NewsRonny SkuggedalApril 7, 2015
PCI Biotech announces positive feedback regarding a patent application in vaccination and immunotherapy NewsRonny SkuggedalMarch 6, 2015
Completion of the third group in the intra-tumour light dose escalation part of the ENHANCE study NewsRonny SkuggedalFebruary 20, 2015
Successful completion of the second dose cohort in the study for patients with inoperable bile duct cancer NewsRonny SkuggedalFebruary 6, 2015
PCI Biotech: Successful Investigational New Drug application (IND) review for Amphinex NewsRonny SkuggedalJanuary 20, 2015
Fully underwritten rights issue of NOK 70 million - link to prospectus and online subscription NewsRonny SkuggedalJanuary 20, 2015
